<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144943">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01213758</url>
  </required_header>
  <id_info>
    <org_study_id>AarhusLiverRadGal</org_study_id>
    <nct_id>NCT01213758</nct_id>
  </id_info>
  <brief_title>Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT</brief_title>
  <official_title>Radiation Induced Change of Liver Function Measured by Uptake of the Galactose Analogue FDGal and PET/CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Danish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients treated with stereotactic radiotherapy for liver tumors undergo PET/CT using the
      galactose analogue 18-F-deoxy-galactose (FDGal) before and after radiotherapy. This
      technique provides volumetric mapping of liver function and it allows quantisation of liver
      function. The method may be used for selection of patients for stereotactic radiotherapy of
      liver tumors, for determination of radiation induced liver dysfunction and may be included
      into the treatment planning process of stereotactic radiotherapy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">May 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uptake of FDGal</measure>
    <time_frame>Before, 1 month and 3 months after stereotactic radiotherapy</time_frame>
    <description>Volumetric uptake of FDGal can be measured is measured by PET/CT</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <condition>Cholangiocarcinoma</condition>
  <condition>Metastases</condition>
  <condition>Stereotactic Body Radiotherapy</condition>
  <arm_group>
    <arm_group_label>Liver tumors</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients where stereotactic body radiation therapy is planned for primary or metastatic liver tumors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measuring liver function by PET/CT</intervention_name>
    <description>Measuring liver function by use of FDGal and PET/CT before, 1 month and 3 months after stereotactic radiotherapy for liver tumors</description>
    <arm_group_label>Liver tumors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  liver tumor

          -  referred for stereotactic radiation therapy

          -  age &gt; 18 years

        Exclusion Criteria:

          -  Impaired kidney function

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Morten Høyer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Morten Høyer, MD PhD</last_name>
    <phone>+45 89492529</phone>
    <email>hoyer@aarhus.rm.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Morten Høyer, MD PhD</last_name>
      <phone>+45 89492529</phone>
      <email>hoyer@aarhus.rm.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.cirro.dk</url>
    <description>The Lundbeck Foundation Centre for Interventional Research in Radiation Oncology</description>
  </link>
  <verification_date>March 2012</verification_date>
  <lastchanged_date>March 21, 2012</lastchanged_date>
  <firstreceived_date>October 1, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver function</keyword>
  <keyword>galactose</keyword>
  <keyword>18-F-deoxy-galactose</keyword>
  <keyword>PET/CT</keyword>
  <keyword>stereotactic body radiation therapy</keyword>
  <keyword>SBRT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Cholangiocarcinoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
